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Biophysics Program, The University of Maryland, College Park, MarylandABSTRACT Prion diseases are fatal neurodegenerative disorders, which are characterized by the accumulation of misfolded
prion protein (PrPSc) converted from a normal host cellular prion protein (PrPC). Experimental studies suggest that PrPC is en-
riched with a-helical structure, whereas PrPSc contains a high proportion of b-sheet. In this study, we report the impact of
N-glycosylation and the membrane on the secondary structure stability utilizing extensive microsecond molecular dynamics sim-
ulations. Our results reveal that the HB (residues 173 to 194) C-terminal fragment undergoes conformational changes and helix
unfolding in the absence of membrane environments because of the competition between protein backbone intramolecular and
protein-water intermolecular hydrogen bonds as well as its intrinsic instability originated from the amino acid sequence. This initi-
ation of the unfolding process of PrPC leads to a subsequent increase in the length of the HB-HC loop (residues 195 to 199) that
may trigger larger rigid body motions or further unfolding around this region. Continuous interactions between prion protein and
the membrane not only constrain the protein conformation but also decrease the solvent accessibility of the backbone atoms,
thereby stabilizing the secondary structure, which is enhanced by N-glycosylation via additional interactions between the
N-glycans and the membrane surface.INTRODUCTIONPrion diseases are an unusual class of fatal mammalian
neurodegenerative disorders, which include scrapie in
sheep, bovine spongiform encephalopathy in cattle, and
Creutzfeldt-Jakob disease, fatal familial insomnia, Gerst-
mann-Stra¨ussler-Scheinker syndrome, and Kuru in humans
(1,2). These diseases affect the central nervous system by
sporadic, genetic, or infectious means (3–6). The funda-
mental events in the pathogenic process of the prion dis-
eases, according to the widely accepted protein-only
hypothesis, involve conversion of the normal cellular form
of prion protein (PrPC) to misfolded scrapie isoforms
(PrPSc), followed by the aggregation of PrPSc into amyloid
fibers and plaques in the brain (7–13). PrPSc and PrPC share
the same primary sequence, and they are chemically indis-
tinguishable (6,14); however, their secondary structures
are remarkably distinct (15–20). Fourier transform infrared
(FTIR) and circular dichroism (CD) spectroscopic studies
reveal that PrPC adopts an a-helix-rich fold (42%) with little
b-sheet structures (3%) (19), whereas PrPSc contains a sig-
nificant b-sheet content (43% to 54% depending on the mo-
lecular length used for measurements) and less helical
structures (17% to 30%) (19,21).
PrPC is expressed in a variety of different tissues,
including the brain with particularly high levels, circulatingSubmitted August 31, 2015, and accepted for publication October 8, 2015.
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0006-3495/15/11/2090/11lymphocytes, heart, and skeletal muscle (22). Despite inten-
sive studies, the precise physiological function of PrPC is
elusive, although there is evidence that PrPC is involved in
the regulation of copper metabolism, signal transduction,
and neuron protection from oxidative stress (23–25). The
solution structures of human, mouse, hamster, and bovine
PrPC fragments have been determined by NMR spectros-
copy (26–30). In contrast, the structural properties of PrPSc
aggregates still remain unresolved by traditional high-
resolution techniques, such as x-ray diffraction and solution
NMR spectroscopy, because of its insoluble nature (21,31).
Human PrPC (HuPrP) 90-230 fragment, generated by N-ter-
minal truncation through digestion with proteinase K, is
considered to be the minimal unit for prion infectivity
(8,32). This fragment is composed of a large un-
structured domain (residues 90 to 124) and a globular
domain (residues 125 to 230) (Fig. 1 A) with three a-helices
(HA: residues 144 to 154, HB: residues 173 to 194, and HC:
residues 200 to 228), a short two-stranded antiparallel
b-sheet (S1: residues 128 to 131 and S2: residues 161 to
164), and a single disulfide bond (Cys179-Cys214) connect-
ing HB and HC.
HuPrP is a glycoprotein with two N-glycosylation sites at
Asn181 and Asn197 (Figs. 1 B and 2), and the glycosylation
sites are variably occupied. The unglycosylated (5%) and
monoglycosylated (25%) isoforms are minor cell-surface
components, whereas the diglycosylated (70%) form is
dominant (34,35). The flexible nature and conformationalhttp://dx.doi.org/10.1016/j.bpj.2015.10.009
FIGURE 1 Snapshots of four PrPC simulation
systems: (A) PrP-only, (B) PrP-nglycan, (C)
PrP-memb, and (D) PrP-nglycan-memb. PrPC,
N-glycan1, N-glycan2, GPI anchor, CHOL,
POPE, and PSM are represented in cartoon (HA,
orange; HB, blue; HC, red), green surface, blue
surface, magenta sticks, light green spheres, light
blue spheres, and light yellow spheres, respec-
tively. Water molecules and KCl ions are omitted
for clarity. To see this figure in color, go online.
Early-Stage Unfolding of HuPrP 2091dynamics of these oligosaccharides make the characteriza-
tion of their structures very challenging by NMR ex-
periments (36). Mutation experiments to omit each
N-glycosylation suggest that PrPC has an intrinsic tendency
to acquire some PrPSc-like properties, and the N-glycan
oligosaccharide chains can modulate the efficiency of this
conversion process (37).
The mature form of PrPC is anchored to the cell mem-
brane via a glycosylphospatidylinositol (GPI) anchor
(Fig. 1, C and D), which is a complex glycophospholipid
present in eukaryotic cells (38). The most fundamental func-
tion of GPI anchors is to provide the efficient and stable
association of protein with the lipid bilayer (39) and also
allow the anchored proteins to have increased mobility
compared to transmembrane proteins (40). Although its
exact function is not clear, abnormalities in GPI synthesis
have been implicated in some diseases such as paro-
xysmal nocturnal hemoglobinuria and embryonic letha-
lity (38,40–42). GPI anchors have diverse structures but
share a conserved core structure: phosphoethanolamine
(EtNP)-Man-a(1/2)-Man-a(1/6)-Man-a(1/4)-GlcN-
a(1/6)-myo-inositol phospholipid (38), where the EtNP
unit is covalently bound to the protein C-terminus (Fig. 2).
After attachment of the GPI anchor to HuPrP Ser230, this
diglycosylated protein is targeted to lipid rafts on the outer
leaflet of the plasma membrane (7,39). Lipid rafts are nano-
or microscale membrane microdomains enriched in choles-
terol (CHOL) and sphingomyelin (PSM) (43–45). They are
postulated to play an important role in membrane trafficking
and cell signaling (46–48).
Exploring the structural and dynamical properties of
membrane-bound PrPC in its native membrane environment
is an important, but challenging task. In this study, we haveperformed extensive molecular dynamics (MD) simulations
to model glycosylated PrPC in a lipid mixture (mimicking a
lipid raft) to investigate the influence of N-glycosylation and
interactions with the membrane on its conformational stabil-
ity at the atomic level and to provide insight into the
possible mechanism of early-stage unfolding of PrPC.MATERIALS AND METHODS
System setup
A HuPrP model with two N-glycans and GPI anchor was constructed by
generating each part of the molecule and linking them together with proper
patches using CHARMM (49). The NMR structure of HuPrP (residues 125
to 228) was obtained from PDB: 1QLX (26) and the two C-terminal missing
residues (Gly229 and Ser230) were added based on CHARMM (49) inter-
nal coordinate (IC) information. The missing unstructured N-terminal res-
idues were ignored. The protonation states were based on pH value of 7
(i.e., neutral His residues and charged acidic and basic residues), which cor-
responds to the extracellular environment (50). Cys179 and Cys214 were
patched together to form a disulfide bond. The N-glycan oligosaccharide
chains (Fig. 2) were generated by connecting all the sugars residues
together and then attaching them to Asn181 and Asn197, respectively.
The identical glycoform was used for both glycosylation sites. For
modeling and simulation of the GPI anchor (Fig. 2), we constructed several
additional CHARMM residues (AGLCNP for GlcN, ETH and ETHN for
EtNP, and DSPI for distearoylphosphatidylinositol) and patches (GPIP1
linkage between DSPI and GlcN, GPIP2 and GPIP4 linkages between
Man and EtNP, and GPIP3 linkage between EtNP and Ser230 of HuPrP).
The force field parameters of these new residues and patches were trans-
ferred by analogy based on the CHARMM36 (C36) lipid (51) and carbohy-
drate (52–54) force field (available at http://mackerell.umaryland.edu/
charmm_ff.shtml) except for the dihedral angle C5-C6-OP1-P1 (in GPIP2
and GPIP4 linkages), which was explicitly parameterized as part of this
study (see the details in the Supporting Material). The sequence and linkage
information for N-glycan and GPI anchor are based on the study of
DeMarco et al. (33). The initial coordinates of the N-glycans and GPIBiophysical Journal 109(10) 2090–2100
FIGURE 2 Sequence and linkage information for HuPrP N-glycan and
GPI anchor oligosaccharide chains (33). To see this figure in color, go
online.
2092 Wu et al.anchor were generated with CHARMM IC functionality and the glycosidic
torsion angles were further refined using the top cluster conformation
searched from Glycan Fragment DB (GFDB: http://www.glycanstructure.
org) (55).
Following the general procedure to build a protein/membrane complex
structure in Membrane Builder (56–58) in CHARMM-GUI (59), the
HuPrP model with the N-glycans and GPI-anchor were preorientated
with respect to the membrane normal (i.e., the z axis), the DSPI phosphate
group was initially positioned around z ¼ 20 A˚, and the orientation of
the inositol ring with respect to the membrane normal was adjusted to
60 according to our recent study about inositol ring orientations in mem-
branes (60). The entire model was then inserted into a CHOL/POPE/PSM
lipid mixture (number of lipids: 145/149/135) to mimic a raft model.
Phosphatidylethanolamine (PE) lipids were chosen because they are
more prevalent than phosphatidylcholine (PC) for neurological myelin
sheath membranes. Spingomyelin (SM) and PE lipids constitute 70% of
phospholipids (in equal proportion) with PC only being 8% (61,62). A
free GPI anchor was inserted into the other leaflet to prevent an area
mismatch in both leaflets and also to examine the conformation of GPI
that is not connected to protein. The rest of the system building followed
the same steps in Membrane Builder (56–58), i.e., building a bulk water
box, addition of Kþ and Cl ions (150 mM), and the assembly of each
component (Fig. 1 D).
In addition to the HuPrP system with the N-glycans and GPI anchor in
a CHOL/POPE/PSM membrane (denoted as PrP-nglycan-memb, see Ta-
ble S1 for system naming in this study), we also constructed three other
systems to explore the impact of the N-glycans and membrane on the struc-Biophysical Journal 109(10) 2090–2100tural stability of PrPC. These include 1) HuPrP in solution (PrP-only:
Fig. 1 A) to represent the recombinant PrP primarily used in in vitro ex-
periments (33), 2) HuPrP with two N-glycans in solution (PrP-nglycan:
Fig. 1 B), and 3) HuPrP only with the GPI anchor in a CHOL/POPE/
PSM membrane (PrP-memb: Fig. 1 C). All molecular graphics was gener-
ated by PyMOL (63).Simulation details
About 4.5-ns equilibration simulation was first performed using
CHARMM (49) with the C36 force fields for the protein (64), lipid
(51,65), carbohydrate (52–54), and TIP3P for water (66). Based on the
equilibration protocol used in CHARMM-GUI Membrane Builder, various
restraints were applied to the protein, lipid, and water molecules to ensure
gradual equilibration (56). The restraint forces were gradually reduced dur-
ing the equilibration. Additional dihedral angle restraints were applied to
restrain the sugar and inositol rings (of the N-glycans and GPI anchor)
to the pertinent chair conformation. The NVT (constant particle number,
volume, and temperature) dynamics was used first and followed by the
NPT (constant particle number, pressure, and temperature) dynamics.
Then, an additional 50-ns NPT equilibration run was performed with
NAMD (67) without any restraints. All equilibration simulations were per-
formed using the following protocol. We used a 2-fs time step with the
SHAKE algorithm (68). The van der Waals interactions were smoothly
switched off at 10 to 12 A˚ by a force-switching function (69) and the
long-range electrostatic interactions were calculated using the particle-
mesh Ewald method (70). The temperature and pressure were held at
300 K and 1 bar, respectively. In CHARMM simulations, Langevin temper-
ature control was used for NVT dynamics. Temperature and pressure con-
trols were achieved with a Hoover thermostat (71) and Langevin-piston
barostat for NPT dynamics (72,73). For NAMD NPT simulations, Lange-
vin dynamics was used to maintain a constant temperature with a Langevin
coupling coefficient set to 1 ps1, and a Nose´-Hoover Langevin-piston
(74,75) was used to maintain constant pressure with a piston period of
50 fs and a piston decay of 25 fs.
For the production run, each system was simulated for 5 ms on Anton
(76) with the CHARMM C36 force fields (51–54,64,65), yielding a total
of 20 ms, which is significantly longer than any previous simulation
studies of similar systems (33). NVT ensemble was used with the tem-
perature maintained at 300 K using the Nose´-Hoover method (77).
Short-range forces and long-range electrostatics were evaluated every 2
and 6 fs, respectively. Long-range electrostatics was calculated using
the k-Gaussian split Ewald method (78) with a 64  64  64 grid.
SHAKE (68) was used to constrain all bonds involving hydrogen atoms
and the time step was 2 fs. Trajectories were saved every 240 ps. The last
4 ms of each trajectory was analyzed to obtain the average structural
properties.RESULTS AND DISCUSSION
Membrane structural properties
Various membrane structural properties were calculated
to evaluate the appropriateness of using the CHOL/
POPE/PSM lipid mixture to mimic a lipid raft. Fig. S1
shows the time series of the membrane hydrophobic thick-
ness of PrP-nglycan-memb and PrP-memb systems by
measuring the average distance between acyl chain C2
atoms (C4S and C2F for PSM) in the top and bottom leaf-
lets. For both bilayers, the calculated hydrophobic thick-
nesses (35 to 36 A˚) are significantly bigger than regular
POPC (28 to 29 A˚) and POPE (31 A˚) bilayers (60,79),
FIGURE 4 Density profiles of some specific residues in (A) GPI anchor
and (B) free GPI for PrP-nglycan-memb (solid lines) and PrP-memb (dotted
lines). The corresponding residues are shown on the top with the same color
scheme. To see this figure in color, go online.
FIGURE 3 Density profiles of water (blue), lipid headgroup (orange),
lipid carbon tail (green), prion protein (gray), N-glycan1 (magenta), and
N-glycan2 (cyan) for PrP-nglycan-memb (solid lines) and PrP-memb
(dotted lines). To aid viewing, the distributions of prion protein, N-glycan1,
and N-glycan2 are scaled by a factor of ten. To see this figure in color,
go online.
Early-Stage Unfolding of HuPrP 2093indicating that the bilayers are in a liquid-ordered state.
The 0.5-A˚ difference between PrP-nglycan-memb and
PrP-memb arises from the fact that the bilayer slightly
expanded in the xy dimension because of the interaction
between the lipids and N-glycans, which will be discussed
below. Consistent with the hydrophobic thickness, lipid
chain order parameters of POPE and PSM (Fig. S2) are
much higher than those in a lipid-disordered state (gener-
ally well below 0.3) (60), suggesting that the current lipid
mixture is reasonable in terms of mimicking an ordered
lipid raft.
The heavy atom density profiles along the bilayer normal
(z axis) for water, lipid components, prion, and N-glycans
are shown in Fig. 3. Lipid carbon tail and headgroup distri-
butions are identical for PrP-nglycan-memb and PrP-memb
systems. As expected from the hydrophobic thickness and
lipid deuterium order parameters, the high chain order is
also reflected with bigger plateau and sharp narrow trough
in the lipid tail distribution. Prion and N-glycans are very
flexible (in terms of their orientations with respect to the
membrane) as shown in their broad distributions, which
overlap with lipid headgroups.
To investigate the domain formation in the membrane and
characterize the nature of the neighbors of the GPI anchor, a
hidden Markov model (HMM) was used to map the two-
dimensional (xy plane) lipid distributions and their order-
states (see Supporting Material). As shown in Fig. S3, there
is no clear domain formation for both leaflets of PrP-ngly-
can-memb and PrP-memb, possibly because of small system
size. The number of the nearest neighbors around each lipid
indicates that there is a slight tendency for POPE aggregation,
whereas it is opposite for CHOL (Fig. S4). Considering that
POPE is in a relatively low order-state (Fig. S3) among these
three lipids, the GPI anchor does not show a preference of any
lipid types in its neighbors given that the number of highorder-
state lipid (sumof PSMandCHOL) and the number of low or-
der-state lipid (POPE) are similar (Fig. S4,A andB). Free GPIprefers higher order-state lipids (PSM and CHOL) (Fig. S4,C
andD). The lipid chain orders of bothGPI anchor and freeGPI
show that they are in the liquid-ordered state (Fig. S5).GPI conformations
The density profiles of the inositol rings and the specific
residues in the terminus of each oligosaccharide branches of
both GPI anchor and free GPI are shown in Fig. 4. Compared
to the distributions of theGPI anchors (Fig. 4A), the freeGPIs
are more flexible with broader distributions (Fig. 4 B), indi-
cating that the conformations of the GPI anchor are more
confined. The distributions of the free GPIs are very similar
for PrP-nglycan-memb and PrP-memb, indicating good sam-
pling over the simulations. For the GPI anchors, the distribu-
tions of mannose (blue) and phosphoethanolamine (green),
which are either close or directly connected to HuPrP, appar-
ently shift away from the membrane with larger z values
in PrP-memb (Fig. 4 A). This is likely a reflection of less
interactions with the membrane when the two N-glycans are
absent, which will be discussed below.HuPrP conformational variations in different
environments
To analyze the overall conformational stability of the


















FIGURE 5 Time series of the root-mean-square deviation (RMSD) of
HuPrP backbone heavy atoms from the starting structure. The structural
alignment was based on the most stable helical portion (HA: residues
144 to 154, HB: residues 173 to 187, and HC: residues 200 to 224). To
see this figure in color, go online.
2094 Wu et al.of HuPrP backbone heavy atoms from the starting structure
were calculated (Fig. 5). The HuPrP conformations of PrP-
nglycan and PrP-only exhibit larger overall RMSD, but the
structures anchored in the membrane (PrP-nglycan-membFIGURE 6 Time series of HuPrP secondary structure (a-helix, red; coil,
(C) PrP-memb, and (D) PrP-nglycan-memb. The secondary structures are de
online.
Biophysical Journal 109(10) 2090–2100and PrP-memb) tend to be more stable with lower RMSD.
The RMSD jumps at ~2 ms in PrP-nglycan and at ~1.5 ms
in PrP-only mainly arise from the loop between HB and
HC (circled in black dash line in Fig. S6) being swung
around.PrP secondary structure stability
PrPC can misfold spontaneously in vivo without mutations
or exposure to infected material (80). As shown in
Fig. S7, the helicity of PrP-only and PrP-nglycan drop
quickly from the beginning of the simulations. In contrast,
the two membrane-containing systems (PrP-nglycan-
memb and PrP-memb) can maintain the integrity of the sec-
ondary structure over the 5-ms simulations.
To better understand the a-helical propensity of HuPrP
amino acid sequence, we investigated the secondary struc-
ture time series for each residue (Fig. 6). For PrP-only
and PrP-nglycan, HB and HC start to unfold and the
length of helices become shorter at the C-terminus early
in the simulations, and the secondary structure of HA fluc-
tuates between helix and coil. For PrP-nglycan-memb and
PrP-memb, HB maintains the helix structure throughout
the simulations with longer HB length in PrP-nglycan-
memb. Residues localized on both HA and HC C-terminigreen; b-sheet, black) of each residue: (A) PrP-only, (B) PrP-nglycan,
fined based on DSSP algorithm (81,82). To see this figure in color, go
FIGURE 7 Hydrogen bond network of HuPrP Thr190 in PrP-nglycan: (A) initial structure, (B) at 62.4 ns, (C) at 63.36 ns, (D) at 63.6 ns, and (E) at 64.32 ns.
Helices are shown in cartoon representation, Thr190 and Gln186 in sticks representation, and other residues including water molecules in line representation.
Hydrogen bonds are shown in black dash lines. To see this figure in color, go online.
Early-Stage Unfolding of HuPrP 2095unfold and fold back multiple times during the simulations.
Furthermore, all four systems exhibit either elongated or
additional b-sheet structure formation transiently. Thus,
most helices unfold to different extents over the simula-
tions in all four systems, with the most unfolding occurring
at the C-termini of the helices. Interestingly, the HB
C-terminus (residues 188 to 194) presents distinct behav-
iors between systems with and without the membrane.
Additionally, the secondary structures of prion protein in
PrP-nglycan-memb and PrP-memb are better preserved
throughout the simulations than those in PrP-only and
PrP-nglycan, which is in good accordance with the afore-
mentioned RMSD analysis.Causes of distinct unfolding behaviors of HB in
different environments
To understand the reason why a pronounced variation of
helical stability of HB exists in different environments, it
is vital to explore how the helix unfolds during the simula-
tion. The HB C-terminus (residues 188 to 194), where
distinct helix unwinding features are found between systems
with and without the membrane, is a fragment with highly
conserved threonine-rich sequence (TVTTTTK). Here,
one threonine residue (Thr190) in PrP-nglycan is selected
as an example to illustrate the unfolding process at the
HB C-terminus. Fig. 7 is a series of snapshots showing the
hydrogen bond network around Thr190 at ~60 ns, when
helix unfolding occurs. In the initial structure, the amide
NH of Thr190 is hydrogen-bonded to the backbone carbonyl
oxygen of Gln186 and the helix is intact (Fig. 7 A).
At 62.4 ns, an additional hydrogen bond is formed be-
tween Gln186 and the hydroxyl oxygen of the Thr190
side chain (Fig. 7 B). This leads to disruption of the back-
bone NH.O hydrogen bond, while the one with the side
chain hydroxyl still remains, so that the helix is distorted
(Fig. 7 C). At 63.6 ns, the remaining hydrogen bond be-
tween Thr190 and Gln186 is broken, and the corresponding
hydroxyl oxygen atom forms hydrogen bonds with water
molecules (Fig. 7 D) leading to further distortion of the he-lix. Right after that, the helix structure at Thr190 unfolds
(Fig. 7 E). It is therefore likely that the competition between
hydrogen bonding of the sidechain hydroxyl with the back-
bone and solvent plays a crucial role in the helix unfolding
mechanism.
To further examine the quantitative contribution of solva-
tion to helix stability, the time series of HuPrP backbone
atoms’ solvent-accessible surface area (SASA) of each res-
idue were analyzed (Fig. 8). As expected, a good correlation
between the PrP secondary structure (Fig. 6) and its SASA
value was observed. For example, when the SASA of a
certain residue increases, the corresponding residue has a
higher tendency to unfold, indicating that solvation contrib-
utes to helix unfolding. For PrP-only and PrP-nglycan, the
increased exposure of the prion protein to water results in
increased helix unwinding. However, for PrP-memb and
PrP-nglycan-memb, the interactions between prion protein
(and N-glycans) and the membrane effectively shield
certain residues from the solvent. This likely explains the
different helix stability in solvent environments (PrP-only
and PrP-nglycan) and in membrane environments (PrP-
memb and PrP-nglycan-memb).
Interactions of the prion protein with the membrane are
responsible for lowering protein-solvent interactions,
which increase the helix stability in PrP-memb and PrP-
nglycan-memb. Then, the question is: What is the role of
the two N-glycans? To answer this question, it is of interest
to examine the interaction pattern of each protein residue
(and N-glycan sugar residues) with lipid molecules or
water in PrP-memb and PrP-nglycan-memb. A cutoff dis-
tance of 5 A˚ was used to define a contact in this analysis,
and the results are presented in Fig. 9. Compared to PrP-
nglycan-memb, the C-terminal regions of HA and HC
form more contacts with the membrane in PrP-memb.
On the other hand, more HB C-terminal residues interact
with the membrane in PrP-nglycan-memb. In addition,
the N-terminus loop and the HA-HB loop also show
more contacts with the membrane. Both N-glycans form
strong and consistent interactions with the membrane,
and some sugar residues penetrate through the lipidBiophysical Journal 109(10) 2090–2100
FIGURE 8 Time series of HuPrP backbone
atoms’ solvent-accessible surface area (A˚2) of
each residue: (A) PrP-only, (B) PrP-nglycan, (C)
PrP-memb, and (D) PrP-nglycan-memb. To see
this figure in color, go online.
2096 Wu et al.headgroup region and interact with lipid aliphatic tails.
N-glycan2 exhibits slightly more interactions with the
membrane (66% of the overall time period) compared to
N-glycan1 (62%). It is worth noting that N-glycan2 is in
the vicinity of the HB C-terminus spatially, so the interac-
tion between N-glycan2 and the membrane could effec-
tively protect residues in HB from interacting with the
solvent and thus unfolding as well.
Based on the interaction pattern comparison between
PrP-memb and PrP-nglycan-memb, it is evident that the
prion protein interacts with the membrane in two differentBiophysical Journal 109(10) 2090–2100modes depending on existence of the N-glycans. Two
representative snapshots are shown in Fig. 10. In PrP-
memb, the HA C-terminal side of the protein points
down and interacts with the membrane (Fig. 10 A), whereas
in PrP-nglycan-memb, the HB C-terminal or N-glycan2
side mainly interacts with the membrane (Fig. 10 B). These
interactions between the prion protein (and N-glycans) and
the membrane can decrease its exposure to solvent and also
provide effective constraints for the protein conformation,
which is essential for stabilizing the protein secondary
structure. The presence of the N-glycans enhances theFIGURE 9 Interaction patterns of HuPrP resi-
dues (and N-glycan sugar residues) with the envi-
ronment components in (A) PrP-memb and (B)
PrP-nglycan-memb. The graph shows, for each res-
idue, the frequency of contact occurrence of a wa-
ter molecule (blue), a headgroup (orange), and a
lipid tail (green). A contact is first counted when
the distance between the heavy atoms of a residue
and those of its interacting partner is within 5 A˚,
and normalized for each interacting partner. The
bar below each set of patterns indicates protein he-
lices (coral) and two N-glycans (green and blue).
To see this figure in color, go online.
FIGURE 10 Representative snapshots of HuPrP
(and N-glycans) on the membrane surface: (A) PrP-
memb and (B) PrP-nglycan-memb. The color
scheme is the same as in Fig. 1: HA, orange; HB,













Early-Stage Unfolding of HuPrP 2097interaction of HB with the membrane, which could poten-
tially facilitate retention of the helical conformation in PrP-
nglycan-memb.
To illustrate the relative position of the prion protein with
respect to the membrane, the time series of the z coordinate
of the center of mass (ZCOM) of the HB C-terminal fragment
(residues 188 to 194), which is unfolded in solution environ-
ments (PrP-only and PrP-nglycan), are shown in Fig. 11.
It is particularly evident that the prion protein’s orientation
with respect to the membrane undergoes considerable
fluctuations considering its rigid conformation (Fig. 5).
Prion protein can tilt over with the HB C-terminus close
to the membrane surface, or it can stay upright with the
HB C-terminus far from the membrane. In general, the pro-
tein displays a rocking motion with the GPI anchor as a
hinge (see Figs. 1 and 10 for different orientations of prion
protein with respect to the membrane). For 79% of the over-
all time period, ZCOM is less than 40 A˚ from the membrane
for PrP-nglycan-memb, whereas it is 61% for PrP-memb,
indicating that the N-glycans effectively enhance the
prion-membrane interactions: e.g., the head group peak oc-
curs at z ¼ 21 A˚ in Fig. 3. Without the N-glycans, the HB
C-terminal residues occasionally detach from the membrane
as evidenced by higher ZCOM between 2 to 4 ms. Although
the HB C-terminal residues remain folded over the 5-ms
simulation for PrP-memb (Fig. 6 C), the loss of contact of
HB with the membrane could potentially lead to unfolding
of the HB C-terminus, leading to the HB C-terminus
in PrP-memb having a higher tendency to unfold compared
to PrP-nglycan-memb. Thus, the prion-membrane interac-
tions are likely required for the maintenance of the protein
secondary structure. Once interactions with the membrane
are lost, helix unfolding could happen because of the back-
bone and solvent hydrogen bonding competition, as dis-
cussed above (Fig. 7). 25
 30
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FIGURE 11 Time series of z coordinates of the center of mass of the
HB C-terminus fragment (residues 188 to 194) in PrP-nglycan-memb
(red) and PrP-memb (blue). To see this figure in color, go online.CONCLUSIONS
The conversion of PrPC to PrPSc is the central event in prion
disease transmission. Despite intense efforts, the conversion
process remains poorly understood. Improving our under-
standing of the early-stage unfolding mechanism of PrPCcould be of great importance for investigation of the subse-
quent misfolding, propagation, and even the treatment of
prion diseases.
In our study, we have concentrated on exploring the
impact of the N-glycosylation and the membrane on prion
secondary structure stability to shed light on the nature of
the conformational instability that drives PrPC to PrPSc via
multiple microsecond MD simulations. Our results demon-
strate that various parts of the globular domain undergo
conformational changes and helices show unfolding to
different extents in different environments. The HB C-ter-
minus (residues 188 to 194), which includes a highly
conserved threonine-rich fragment, exhibits significant
instability in the absence of the membrane but remains he-
lical in the presence of the membrane. The dominant factor
responsible for instability of the HB C-terminus is competi-
tion between the protein backbone intramolecular iiþ4
hydrogen bonds with both the solvent and side chains,
with the latter implicating the role of the intrinsic amino
acid sequence on stability of this fragment. It was experi-
mentally revealed that this HB peptide fragment has an
inherently high propensity for b-strands and tends to form
b-sheet-rich amyloid-like fibrils (8,83). Surewicz’s labBiophysical Journal 109(10) 2090–2100
2098 Wu et al.also showed that the conformational conversion of PrPC in-
volves major refolding of the C-terminal a-helical region,
and the HB-HC subdomain has been shown to be part of
the b-sheet core by site-directed spin labeling EPR spectros-
copy and hydrogen/deuterium exchange (84,85). Although
it will be challenging to observe folding from a coiled
conformation to a b-sheet in accessible simulation times,
it is tempting to speculate that unfolding of the HB C-termi-
nus and the subsequently increased flexibility in the HB-HC
loop in our simulations represent the starting point that trig-
gers the PrPC / PrPSc pathological conversion pathway.
Moreover, CD and NMR studies by Ziegler et al. suggested
that HA has a high intrinsic helical propensity and is un-
likely to be involved in the initial steps of the pathogenic
conformational change (86), which also agrees with the
relative stability of HA compared to HB in our solution
simulations.
The interactions between protein and membrane can pro-
vide effective constraints on the protein conformation and
decrease the solvent accessibility of the protein backbone,
thus stabilizing the protein secondary structure. In the
case of HuPrP, the two N-glycans can enhance such
interactions by forming more contacts with the membrane
surface, thereby stabilizing protein-membrane interactions.
Although the helical structure of the HB C-terminus is re-
tained in both PrP-nglycan-memb and PrP-memb on the
timescale of our current simulations, its position remains
close to the membrane surface (<40 A˚) for longer period
of time when both N-glycans are present. More frequent
detachment of HB from the membrane surface without
N-glycans could result in increased exposure to solvent
and potentially acquiring PrPSc-like conformation compared
to PrP-nglycan-memb.SUPPORTING MATERIAL
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